CVS Health Corporation (CVS)

NYSE: CVS · USD

$106

-3.42 (-3.1%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-30 02:00 UTC. Latest published research analyzed 2026-05-13 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh CVS analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-13

Our latest published analysis: CVS rated Hold

Hold. The stock trades at a premium to our intrinsically sound $86.81 fair value midpoint. While robust >$7B FCF acts as a defensive buffer, extreme leverage and Medicare Advantage margin compression strictly cap actionable upside.

Fair value (mid)

$86.8 / share

$62.5 – $112

Upside to FV

-8.8%

from $106

Confidence

88/100

Moat

6.5/10

Market cap	$121.4B
Revenue (ttm)	405.6B
Net income (ttm)	2.9B
EPS (ttm)	$2.30
Shares out	1.3B
P/E (trailing)	46.1x
P/E (forward)	11.4x
Dividend	$2.66 (2.51%)
Volume	7,718,978
Beta	0.60
Price target	$112	+5.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 405.6B
Net income (ttm): 2.9B
EPS (ttm): $2.30
P/E (trailing): 46.1x
P/E (forward): 11.4x
Market cap: $121.4B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	—	$322.47B	$357.78B	$372.81B	$402.07B	+5.7%
Gross profit	—	$54.50B	$54.43B	$51.40B	$55.36B	+0.4%
Operating income	—	$16.29B	$14.60B	$9.70B	$10.39B	-10.6%
Net income	—	$4.31B	$8.34B	$4.61B	$1.77B	-20.0%
EPS (diluted)	$5.95	$3.26	$6.47	$3.66	—	-11.4%
EBITDA	—	$12.35B	$18.20B	$13.70B	$9.86B	-5.5%
R&D	—	—	—	—	—	—
SG&A	—	—	—	—	—	—

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All CVS indicators

Market & fundamental data

Available fields

294

Groups with data

Currency

USD

Showing 294 of 294 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000064803
Company name	CVS Health Corporation
Country	United States
Country code	US
Cusip	126650100
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$201.7B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Healthcare Plans
Industry PE	32.24
Industry PE Fwd	16.61
Isin	US1266501006
Last refreshed	2026-07-30
Market cap	$135.1B
Market cap category	Large-Cap
Price	$106
Price currency	USD
Rev Per Employee	1,352,060x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	5912
Symbol	CVS
Tags	pharmaceuticals
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.17%
EV Earnings	68.79x
EV Sales Forward	0.49x
EV/EBIT	33.81x
EV/EBITDA	33.81x
EV/FCF	27.28x
EV/Sales	0.5x
FCF yield	5.47%
Forward P/E	13.85x
P/B ratio	1.74x
P/E ratio	46.14x
P/S ratio	0.33x
PE Ratio10 Y	23.11x
PE Ratio3 Y	36x
PE Ratio5 Y	30x
PEG ratio	1.16x
PS Forward	0.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.46%
EBITDA Margin	1.46%
FCF margin	1.82%
Gross margin	13.39%
Gross Profit	$54.3B
Gross Profit Growth	6.44%
Gross Profit Growth Q	8.46%
Gross Profit Growth3 Y	0.51%
Gross Profit Growth5 Y	2.25%
Net Income	$2.9B
Net Income Growth	-44.47%
Net Income Growth Q	65.43%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-16.89%
Pretax Margin	0.85%
Profit Margin	0.72%
Profit Per Employee	$9,773
Profitable Quarters	$2
Profitable Years	7
ROA	2.67
Roa5y	3.25
ROCE	3.58
ROE	3.75
Roe5y	7.3
ROIC	6.3
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.44%
Cagr15y	10.16%
Cagr1y	83.31%
Cagr20y	8.37%
Cagr3y	16.76%
Cagr5y	8.46%
Div CAGR10	5.05%
Div CAGR3	4%
Div CAGR5	5.87%
EPS Growth	-45.23
EPS Growth Q	63.12
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-9.68
EPS Growth5 Y	-16.38
FCF Growth	24.46%
FCF Growth Q	-10.83%
FCF Growth3 Y	-24.81%
FCF Growth5 Y	-10.57%
OCF Growth	17.95%
OCF Growth Q	-6.74%
OCF Growth10 Y	1.54%
OCF Growth3 Y	-19.83%
OCF Growth5 Y	-7.73%
Revenue Growth	7.67x
Revenue Growth Q	6.15x
Revenue Growth Quarters	52x
Revenue Growth Years	15x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.6
Assets	$253B
Cash	$11.8B
Current Assets	$74.8B
Current Liabilities	$86.4B
Debt	$78.3B
Debt EBITDA	$13.13
Debt Equity	$1.01
Debt FCF	$10.6
Equity	$77.6B
Interest Coverage	1.92
Liabilities	$175.3B
Long Term Assets	$178.2B
Long Term Liabilities	$88.9B
Net Cash	$-66.5B
Net Cash By Market Cap	$-49.24
Net Debt EBITDA	$11.15
Net Debt Equity	$0.86
Net Debt FCF	$9
Tangible Book Value	$-33.1B
Tangible Book Value Per Share	$-26
WACC	6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	19.99
Net Working Capital	$-18.9B
Quick ratio	0.61
Working Capital	$-11.6B
Working Capital Turnover	$-29.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$2.66
Dividend Years	56
Dividend Yield	2.51%
Ex Div Date	2026-07-23
Last Dividend	$0.67
Payout Frequency	Quarterly
Payout Ratio	115.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	54.43%
1Y total return	83.24%
200-day SMA	84.31
3Y total return	59.19%
50-day SMA	100.7
50-day SMA vs 200-day SMA	50over200
5Y total return	50.09%
All Time High	113.7
All Time High Change	-6.8%
All Time High Date	2015-07-29
All Time Low	0.3
All Time Low Change	35,575.31%
All Time Low Date	1974-12-23
ATR	2.61
Beta	0.6
Beta1y	0.34
Beta2y	0.52
Ch YTD	33.47
High	110
High52	110.7
High52 Date	2026-07-22
High52ch	-4.3%
Low	105.8
Low52	58.99
Low52 Date	2025-07-29
Low52ch	79.56%
Ma50ch	5.17%
Premarket Change Percent	0.33
Premarket Price	$110
Premarket Volume	15,570
Price vs 200-day SMA	25.63%
RSI	53.17
RSI Monthly	68.38
RSI Weekly	70.36
Sharpe ratio	2.01x
Sortino ratio	3.06
Total Return	1.44%
Tr YTD	36.59
Tr15y	326.83%
Tr1m	2.14%
Tr1w	-1.39%
Tr3m	31.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	28
Analyst Count Top	15
Analyst Price Target Top	$112
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.84
Earnings EPS Estimate Growth	1.66
Earnings Revenue Estimate	100,092,418,792x
Earnings Revenue Estimate Growth	1.21x
Operating Income	$10.8B
Operating Income Growth	16.19
Operating Income Growth Q	25.09
Operating Income Growth3 Y	-10.92
Operating Income Growth5 Y	-4.45
Operating margin	2.67
Price target	$112
Price Target Change	$5.92
Price Target Change Top	$5.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,273,215,085%
Float Percent	99.79%
Net Borrowing	-1,695,000,000
Shares Insiders	0.09%
Shares Institutions	89.69%
Shares Out	1,275,927,307
Shares Qo Q	0.16%
Shares Yo Y	1.07%
Short Float	1.53%
Short Ratio	2.47
Short Shares	1.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$6.7B
Adjusted OCF	9,657,000,000
Average Volume	7,405,817.7x
Bv Per Share	60.85
CAPEX	$-2.9B
Ch10y	13.42
Ch15y	190.8
Ch1m	1.51
Ch1w	-2
Ch1y	77.6
Ch20y	225
Ch3m	30.8
Ch3y	41.97
Ch5y	27.16
Ch6m	43.08
Change	-3.13%
Change From Open	-3.71
Close	109.3
Days Gap	0.6
Depreciation Amortization	4,567,000,000
Dollar Volume	817,594,149.8
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$6B
EBITDA	$6B
EPS	$2.3
F Score	6
FCF	$7.4B
FCF EV Yield	3.67x
FCF Per Share	$5.8
Financing CF	-4,926,000,000
Fiscal Year End	December
Founded	1,963
Goodwill	85,478,000,000
Graham Number	56.05835
Graham Upside	-47.07
Income Tax	$554M
Investing CF	-5,983,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2005-06-07
Last Split Type	Forward
Last10k Filing Date	2026-02-10
Lynch Fair Value	$11.48
Lynch Upside	-89.16
Ma150	86.07
Ma150ch	23.07%
Ma20	106.1
Ma20ch	-0.2%
Net CF	-577,000,000
Next Earnings Date	2026-08-05
Open	110
Optionable	Yes
P FCF Ratio	18.28
P FCF Ratio SBC	20.11
P OCF Ratio	13.08
P OCF Ratio SBC	13.99
Payment Date	2026-08-03
Position In Range	1.92
Post Close	105.9
Postmarket Change Percent	0.24
Postmarket Price	$106
Ppne	27,778,000,000
Pre Close	109.3
Price Date	2026-07-29
Price EBITDA	$22.65
Relative Volume	1.04x
Revenue	405,618,000,000x
SBC By Revenue	0.17x
Share Based Comp	675,000,000
Tax By Revenue	0.14x
Tax Rate	16.03%
Tr20y	399.42%
Tr6m	45.23%
Us State	Rhode Island
Views	231
Volume	7,718,978
Z Score	2.35

Frequently asked questions

About this CVS report

What is the latest published CVS stock rating?

CVS Health Corporation is shown with hold in the latest published report, analyzed 2026-05-13. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CVS analysis?

The full latest published report, analyzed 2026-05-13, lives at /stocks/CVS/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for CVS?

The latest published report analyzed 2026-05-13 frames CVS around USD 62 to USD 112. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the CVS page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-13). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

CVS Health Corporation (CVS)

Coverage state: Latest published research available

Generate a fresh CVS analysis

Our latest published analysis: CVS rated Hold

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CVS

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All CVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CVS

Frequently asked questions